Form 4: Exact Sciences Executive Brian Baranick Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
EVP and GM of Precision Oncology at Exact Sciences, Brian Baranick, reports the vesting of restricted stock units and subsequent stock transactions for tax withholding.
Summary
- Brian Baranick, EVP and GM of Precision Oncology at Exact Sciences, filed a Form 4 detailing changes in beneficial ownership.
- The transactions occurred on February 28, 2025, and involved the vesting of restricted stock units (RSUs) and the subsequent withholding of shares for tax purposes.
- Baranick received 4,725 shares and 4,948 shares of common stock upon the vesting of RSUs.
- A total of 2,400 and 2,513 shares were withheld by Exact Sciences for tax obligations at a price of $47.82 per share.
- Following these transactions, Baranick directly owns 22,593 shares of common stock and indirectly owns 670 shares held in a 401(k) plan.
- He also holds 9,450 and 14,845 derivative securities in the form of restricted stock units.
- Baranick also holds an additional 78,430 vested and unvested options to purchase shares of Common Stock and restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value.
- Tax withholding practices related to RSU vesting are standard across publicly traded companies.
- Form 4 filings are a standard regulatory requirement for reporting insider transactions, ensuring transparency and preventing insider trading.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation.
- Employees holding RSUs are affected by the vesting schedule and tax implications.
Key Dates
| Date | Description |
|---|---|
| 2023-02-24 | Date of restricted stock unit award that partially vested on February 28, 2025. |
| 2024-02-26 | Date of restricted stock unit award that partially vested on February 28, 2025. |
| 2025-02-28 | Date of transaction: vesting of restricted stock units and tax withholding. |
| 2025-03-04 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.